Endocrine Flashcards
(294 cards)
Define hyperthyroid disease/thyrotoxicosis
(NB: this section includes Grave’s, thyroid nodules, viral thyroiditis)
Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland,
whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source
Thyrotoxicosis may be either due to increased thyroid hormone synthesis (hyperthyroidism) OR increased release of stored thyroid hormone from an inflamed thyroid gland (thyroiditis)
Explain the aetiology / risk factors of hyperthyroid disease/ thyrotoxicosis
Please read the definition of these two things, it’s very important
A bit of detail on the cause of grave’s
What antibody type?
Thyrotoxicosis= umbrella term for both hyperthyroidism (i.e. overactive thyroid) and thyroiditis (release of thyroid stored thyroid hormone from an inflamed thyroid gland)
Hyperthyroidism:
- Primary
1. Grave’s disease (=Plasma IgG to thyroid TSH receptor stimulates thyroid hyperplasia and thyroid hormone hypersecretion, causing exaggerated thyroid hormone action and autonomic overactivity.)
2. Toxic multinodular goitre
3. Single toxic adenoma - Secondary
4. TSH-secreting pituitary tumours
5. TSH producing tumours
Choriocarcinoma (raised hCG, which is structurally similar to TSH)
Thyroiditis:
- Post partum
- De Quervain’s (post viral)
Drugs: amiodarone &; self administration of T4
RISK FACTORS
- Grave’s: other AI diseases
- Toxic multinodular: older women
Summarise the epidemiology of hyperthyroid disease/ thyrotoxicosis (IMPORTANT)
Thyrotoxicosis affects 1% of all females and 0.1% of all males.
Grave’s disease accounts for 70-80% of all cases of hyperthyroidism
Toxic multinodular goitre most common cause of hyperthyroidism in the elderly
Recognise the presenting symptoms of hyperthyroid disease/thyrotoxicosis
How might you use these to differentiate the different causes
GENERAL thyrotoxicosis symptoms:
- Heat intolerance, sweating, anxiety and irritability, palpitations
- Weight loss (BUT INCREASED APPETITE), diarrhoea, pruritis
- Tremor
- Menstrual irregularities in females
- Reduced libido, impotence in males
SPECIFICS:
- de Quervain’s thyroiditis: fever, malaise and pain in the neck (tender goitre)
- Grave’s: opthalmopathy (blurred vision, double vision, eye grittiness, eye protrusion)
Recognise the signs of hyperthyroid disease/thyrotoxicosis on physical examination
How might you use these to differentiate the different causes
What are the signs specifically of a thyroid crisis
GENERAL:
- Underweight, restless, irritable, sweating. Signs of associated AI conditions (vitiligo)
- Warm vasodilated peirpheries, systolic HTN, cardiac failure
- Rapid irregular pulse, palmar erythema,
- Proximal myopathy
GRAVE’S SPECIFIC:
- Dermopathy: thyroid acropachy (clubbing) , pretibial myxoedema
- Exophthalmos, lid lag & stare, ophthalmoplegia, periorbital oedema
Thyroid crisis : Hyperpyrexia, signs of dehydration, tachycardia, restlessness, coma.
Identify appropriate investigations for hyperthyroid disease/thyrotoxicosis and interpret the results
How might you use these to differentiate the different causes
Thyroid function tests: Primary hyperthyroidism (increased T4, T3, reduced TSH) Secondary hyperthyroidism (increased T4, T3, raised or inappropriately normal TSH)
Radioisotope uptake scan (99 technetium pertechnetate):
- Grave’s: diffuse increased uptake
- Toxic multinodular goitre: multiple areas of increased radio-isotope uptake (hot nodules) WITH suppression of uptake in the rest of the gland
- Solitary toxic adenoma: single area of “ radio-isotope uptake (hot nodules) with suppression of uptake in the rest of the gland.
- de Quervain’s thyroiditis: absent uptake
TSH receptor stimulating antibodies: positive in Grave’s disease (expensive, and the aetiology can be established using the above)
CT/MRI of orbits (STIR sequence- nulls signal from fat): Assessment and follow-up of patients with Grave’s opthalmology
Describe pretibial myxoedema
raised pigmented orange-peel textured nodules or plaques on the shins
specific to Grave’s disease
Explain proctosis in Grave’s disease, what is the name for it specifically?
secondary to increased glycosaminoglycans secreted by fibroblasts stimulated by activated T cell cytokines and TSH receptor antibodies
called exopthalmos
Management of hyperthyroidism/thyrotoxicosis
Indications for each
- Medical
- Anti-thyroid drugs: carbimazole, propylthiouracil (both inhibit thyroid peroxidase and hormone synthesis)
Rarely cause agranulocytosis. Must be stopped and have FBC checked if develop fever, sore throat, mouth ulcers or other signs of infection. If this toxicity occurs, propylthiouracil used instead
After 4-6 weeks at full dose, carbimazole gradually reduced over 6-24 months and discontinued when patient is euthyroid. 50% of patients with Grave’s relapse and then need further treatment (radioactive iodine or surgery)
- KI: Inorganic iodide given in pharmacological doses (as Lugol׳s solution or as saturated solution of potassium iodide, SSKI) decreases its own transport into the thyroid, inhibits iodide organification (the Wolff–Chaikoff effect), and rapidly blocks the release of T4 and T3 from the gland. ALSO REDUCES VASCULARITY OF THE GLAND (see why this is relevant in “surgery”)
- b blockers (as clinical benefit not apparent for 10-20 days, b blockers provide symptomatic control)
- Radio-iodine
- Must avoid pregnancy/breast feeding for 4 months and close contact with pregnant women and young children for 2 weeks after radioactive iodine therapy.
It accumulates in the gland and results in local irradiation over 4-12 wks.
- Surgery:
- Reserved for patients with large goitres causing upper airway obstruction or dysphagia, and those who cannot take ATD (e.g. due to allergy/agranulocytosis) and are either pregnant or have moderate/severe Graves’ ophthalmopathy (which may be exacerbated by radioiodine).
Should only be performed in patients who have been rendered euthyroid. ATD stopped 10-14 days before operation and replaced with oral PI which inhibits thyroid hormone release AND reduces vascularity of the gland
Pre-operative prep: control hyperthyroidism with ATD, give oral potassium iodide and propanolol. Examination of vocal cords by ENT specialists
Lifelong measurement of TSH to look for hypothyroidism is indicated after surgery or radioiodine treatment
Ophthalmopathy : Corneal protection (artificial tears, lateral tarsorrhaphy), surgery for realignment
Complications of hyperthyroidism/thyrotoxicosis
Thyrotoxic crisis. Heart failure. Osteoporosis. Infertility. Complications of surgery (recurrent laryngeal nerve palsy, hypothyroidism, hypoparathyroidism) or radioiodine (exacerbation of ophthalmopathy, hypothyroidism, recurrence).
Patients with subclinical hyperthyroidism have increased long-term risk of atrial fibrillation and reduced bone density.
Prognosis of hyperthyroidism/thyrotoxicosis
Many patients eventually become hypothyroid
Differentiate the two types of amiodarone induced hyperthyroidism
…..
….
……
Define prolactinoma
Physiological reasons for huperprolactinaemia
Prolactin release under tonic inhibition by dopamine from hypothalamus.
Physiological reasons: pregnancy, lactation and severe stress
Explain the aetiology / risk factors of prolactinoma
do general causes of hyperprolactinaemia
Commonest cause of hyperprolactinaemia is a prolactinoma
- Prolactin secreting adenoma (prolactinoma)
- Other pituitary/hypothalamic (e.g. craniopharyngioma) tumours can cause hyperprolactinaemia by interfering with dopamine inhibition (due to stalk compression) or prolactin release.
- Use of a dopamine antagonist (e.g. metaclopramide haloperidol) or other drugs (e.g. oestrogens, ecstasy)
Other causes of primary hypothyroidism (because TRH levels stimulate prolactin)
PCOS
Acromegaly (co-secretion of prolactin with GH by the tumour)
Note that a PRL >5000 is likely to be a prolactinoma
Summarise the epidemiology of prolactinoma
.
Recognise the presenting symptoms/signs of prolactinoma (do hyperprolactinaemia generally)
Macroprolactinoma?
Hyperprolactinaemia presents earlier in women (menstrual disturbance) than men (erectile dysfunction/mass effects)
Galactorrhoea in women
Amenorrhoea/oligomenorrhoea (as prolactin inhibits GnRH)
Decreased libido, subfertility and erectile dysfunction in men.
Osteoporosis
Local effects of headache and visual field defects if there is a pituitary tumour
Macroprolactinoma:
-reduced visual acuity, diplopia, opthalmoplegia, visual field loss and optic atrophy
Identify appropriate investigations for prolactinoma and interpret the results
Basal PRL; non stressful venepuncture between 9am and 4pm. PREGNANCY TEST, TFT, U&E, MRI pituitary if other causes ruled out
Generate a management plan for prolactinoma
What is macroprolactinoma
What is preferred in pregnancy
FOR MICRO-prolactinomas
Dopamine agonists first line e.g. bromocriptine and cabergoline. BROMOCRIPTINE PREFERRED IN PREGNANCY
Bromocriptine reduces PRL and also reduces tumour size
Transphenoidal surgery if intolerant of dopamine agonists.
FOR MACRO-prolcatinomas:
A tumour >10mm on MRI. Treat initially with dopamine antag (bromocriptineif fertility is the goal). Surgery rarely needed BUT considered if there are visual symptoms or pressure effects which fail to respond to medical treatment.
Bromocriptine and in some cases radiation therapy, may be required post-op as complete surgical resectuin is uncommon.
Identify the possible complications of prolactinoma and its management
Increased risk of expansion of (macro)prolactinoma when pregnant (you have to check visual fields (perimetry) if pregnant because prolactin level will be off anyway
Management complications:
Bromocriptine SEs: nausea, depression, postural hypotension (give at night). If pregnancy is planned, use barrier contraception until 2 periods have occurred. If they get pregnant, stop bromocriptine after 1st missed period
Cabergoline (an ergot alkaloid) can cause fibrosis (echos needed), but generally has less SEs than bromocriptine, but less data of safety of this drug during pregnancy
Transphenoidal surgery: high success rate but risks of permanent hormone deficiency and prolactinoma recurrence, so usually reserved as 2nd line
Summarise the prognosis for patients with prolactinoma
.
What are the 3 major conditions usually caused by secretion from pituitary adenomas
GH excess –> gigantism in children and acromegaly in adults
Prolactin excess –> causing galactorroea or clinically silent
Excess ACTH secretion –> cushings disease and nelsons syndrome
What are the local effects of pituirary adenoma
- Optic chiasm causing a bitemporal hemianopia
- Cavernous sinus with II, IV nad VI cranial nerve lesions
- Bony structures and the meninges cuasing headache
- Hypothalamic centres: obesity, altered appetite and thirst, prcocious puberty
- The ventricles, cuasing interruption of CSF and hydrocephalus
Define carcinoid syndrome
A consetllation of symptoms caused by systemic release of “humoral factors” (note humoral here is talking about hormones)
E.g. tumour of neuroepithelial cells. You can have a carcinoid tumour that is benign and doesn’t release anything, in which cause it isn’t carcinoid syndrome